These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37976519)

  • 1. Pediatric Pars Planitis: A Review.
    Khochtali S; Ozdal P; AlBloushi AF; Nabi W; Khairallah M
    Ocul Immunol Inflamm; 2023 Dec; 31(10):1915-1929. PubMed ID: 37976519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis.
    Ozdal PC; Berker N; Tugal-Tutkun I
    J Ophthalmic Vis Res; 2015; 10(4):469-80. PubMed ID: 27051493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of clinical features and visual outcomes of pars planitis.
    Berker N; Sen E; Elgin U; Atilgan CU; Dursun E; Yilmazbas P
    Int Ophthalmol; 2018 Apr; 38(2):727-736. PubMed ID: 28389773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of pars planitis-associated cystoid macular edema on visual outcome and management in children.
    Navarrete A; Koriat A; Amer R
    Graefes Arch Clin Exp Ophthalmol; 2020 Aug; 258(8):1803-1811. PubMed ID: 32346784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermediate Uveitis: A Review.
    Teo AYT; Betzler BK; Hua KLQ; Chen EJ; Gupta V; Agrawal R
    Ocul Immunol Inflamm; 2023 Jul; 31(5):1041-1060. PubMed ID: 35759636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complications in Intermediate Uveitis: Prevalence, Time of Onset, and Effects on Vision in Short-Term and Long-Term Follow-Up.
    Sancho L; Kramer M; Koriat A; Eiger-Moscovich M; Sharon Y; Amer R
    Ocul Immunol Inflamm; 2019; 27(3):447-455. PubMed ID: 29370567
    [No Abstract]   [Full Text] [Related]  

  • 7. Visual outcomes after pars plana vitrectomy for epiretinal membranes associated with pars planitis.
    Dev S; Mieler WF; Pulido JS; Mittra RA
    Ophthalmology; 1999 Jun; 106(6):1086-90. PubMed ID: 10366075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of peripheral laser photocoagulation in pars planitis.
    Pulido JS; Mieler WF; Walton D; Kuhn E; Postel E; Hartz A; Jampol LM; Weinberg DV; Logani S
    Trans Am Ophthalmol Soc; 1998; 96():127-37; discussion 137-41. PubMed ID: 10360286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pars planitis in children: epidemiologic, clinical, and therapeutic characteristics.
    Romero R; Peralta J; Sendagorta E; Abelairas J
    J Pediatr Ophthalmol Strabismus; 2007; 44(5):288-93. PubMed ID: 17913171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and treatment of pars planitis: an adalimumab experience.
    Ozdemir HB; Ozdal PC
    Graefes Arch Clin Exp Ophthalmol; 2022 Feb; 260(2):561-569. PubMed ID: 34568953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermediate uveitis in a pediatric Italian population.
    Paroli MP; Spinucci G; Monte R; Pesci FR; Abicca I; Pivetti Pezzi P
    Ocul Immunol Inflamm; 2011 Oct; 19(5):321-6. PubMed ID: 21970663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2 peripheral scatter photocoagulation for neovascularization associated with pars planitis.
    Park SE; Mieler WF; Pulido JS
    Arch Ophthalmol; 1995 Oct; 113(10):1277-80. PubMed ID: 7575259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial pars planitis.
    Lee AG
    Ophthalmic Genet; 1995 Mar; 16(1):17-9. PubMed ID: 7648038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pars planitis.
    Henderly DE; Genstler AJ; Rao NA; Smith RE
    Trans Ophthalmol Soc U K (1962); 1986; 105 ( Pt 2)():227-32. PubMed ID: 3467497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pars plana vitrectomy as anti-inflammatory therapy for intermediate uveitis in children].
    Figueroa MS; Noval S; Contreras I; Arruabarrena C; García-Pérez JL; Sales M; Gil-Cazorla R
    Arch Soc Esp Oftalmol; 2010 Dec; 85(12):390-4. PubMed ID: 21354506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pars plana vitrectomy in patients with intermediate uveitis.
    Stavrou P; Baltatzis S; Letko E; Samson CM; Christen W; Foster CS
    Ocul Immunol Inflamm; 2001 Sep; 9(3):141-51. PubMed ID: 11815883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical symptoms and complications of pars planitis in childhood.
    Maris K; Van Calster J; Wouters C; Casteels I
    Bull Soc Belge Ophtalmol; 2005; (295):29-33. PubMed ID: 15849986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunopathogenic Background of Pars Planitis.
    Przeździecka-Dołyk J; Węgrzyn A; Turno-Kręcicka A; Misiuk-Hojło M
    Arch Immunol Ther Exp (Warsz); 2016 Apr; 64(2):127-37. PubMed ID: 26438050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phakic patients with cystoid macular edema, retinal periphlebitis, and vitreous inflammation.
    Park DW; Folk JC; Whitcup SM; Polk TD; Kansupada K; Fountain C; Brown J; Nussenblatt RB
    Arch Ophthalmol; 1998 Aug; 116(8):1025-9. PubMed ID: 9715682
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.